Skip to content
healthcare.dev

HYDROMORPHONE HYDROCHLORIDE

NDC 43602-002, hydromorphone hydrochloride, tablet, from Ascent Pharmaceuticals Inc.

Product NDC
43602-002
Status
Listed
Labeler
Ascent Pharmaceuticals Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210506
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43602-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROMORPHONE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

Package NDCNDC-11Package
43602-002-0543602000205500 TABLET in 1 BOTTLE (43602-002-05)
43602-002-304360200023030 TABLET in 1 BOTTLE (43602-002-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4de15afe-d676-4faa-a34d-9b9cb20dbf54

Use it

Look up 43602-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43602-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43602-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.